Targeting Glioblastoma Stem Cells to Overcome Chemoresistance: An Overview of Current Therapeutic Strategies

Glioblastoma (GBM) is the most malignant primary brain tumor. The current standard approach in GBM is surgery, followed by treatment with radiation and temozolomide (TMZ); however, GBM is highly resistant to current therapies, and the standard of care has not been revised over the last two decades,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Hyunkoo, Lee, Haksoo, Kim, Dahye, Kim, Byeongsoo, Kang, JiHoon, Kim, Hae Yu, Youn, HyeSook, Youn, BuHyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220281/
https://www.ncbi.nlm.nih.gov/pubmed/35740330
http://dx.doi.org/10.3390/biomedicines10061308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220281/
https://www.ncbi.nlm.nih.gov/pubmed/35740330
http://dx.doi.org/10.3390/biomedicines10061308

Ejemplares similares